Li Y, Yan B, He S. Advances and challenges in the treatment of lung cancer. Biomed Pharmacother = Biomed Pharmacother. 2023;169:115891.
Article CAS PubMed Google Scholar
Król K, Mazur A, Stachyra-Strawa P, Grzybowska-Szatkowska L. Non-small cell lung cancer treatment with molecularly targeted therapy and concurrent radiotherapy-a review. Int J Mol Sci. 2023;24(6):5858.
Kundu M, Butti R, Panda VK, Malhotra D, Das S, Mitra T, Kapse P, Gosavi SW, Kundu GC. Modulation of the tumor microenvironment and mechanism of immunotherapy-based drug resistance in breast cancer. Mol Cancer. 2024;23(1):92.
Orrantia-Borunda E, Anchondo-Nuñez P, Acuña-Aguilar LE, Gómez-Valles FO, Ramírez-Valdespino CA. Subtypes of breast cancer. Breast Cancer. 2022, Available online: https://www.ncbi.nlm.nih.gov/books/NBK583808/
Jin L, Han B, Siegel E, Cui Y, Giuliano A, Cui X. Breast cancer lung metastasis: molecular biology and therapeutic implications. Cancer Biol Ther. 2018;19(10):858–68.
Article CAS PubMed Google Scholar
Medeiros B, Allan AL. Molecular mechanisms of breast cancer metastasis to the lung: clinical and experimental perspectives. Int J Mol Sci. 2019;20(9):2272.
Article CAS PubMed Google Scholar
Lin SR, Chang CH, Hsu CF, Tsai MJ, Cheng H, Leong MK, Sung PJ, Chen JC, Weng CF. Natural compounds as potential adjuvants to cancer therapy: preclinical evidence. Br J Pharmacol. 2020;177(6):1409–23.
Article CAS PubMed Google Scholar
Majolo F, Delwing LKDOB, Marmitt DJ, Bustamante-Filho IC, Goettert MI. Medicinal plants and bioactive natural compounds for cancer treatment: ımportant advances for drug discovery. Phytochem Lett. 2019;31:196–207.
Noel B, Singh SK, Lillard JW Jr, Singh R. Role of natural compounds in preventing and treating breast cancer. Front Biosci (Schol Ed). 2020;12:137.
Sharifi-Rad J, Quispe C, Patra JK, Singh YD, Panda MK, Das G, Adetnji CO, Michael OS, Sytar O, Polito L, et al. Paclitaxel: application in modern oncology and nanomedicine-based cancer therapy. Oxid Med Cell Longev. 2021;2021(1):3687700.
Ma P, Mumper RJ. Paclitaxel nano-delivery systems: a comprehensive review. J Nanomed Nanotechnol. 2013;4(2):1000164.
Asnaashari S, Amjad E, Sokouti B. Synergistic effects of flavonoids and paclitaxel in cancer treatment: a systematic review. Cancer Cell Int. 2023;23(1):211.
Ashrafizadeh M, Zarrabi A, Hashemi F, Moghadam ER, Hashemi F, Entezari M, Hushmandi K, Mohammadinejad R, Najafi M. Curcumin in cancer therapy: a novel adjunct for combination chemotherapy with paclitaxel and alleviation of its adverse effects. Life Sci. 2020;256:117984.
Article CAS PubMed Google Scholar
Vemuri SK, Halder S, Banala RR, Rachamalla HK, Devraj VM, Mallarpu CS, Neerudu UK, Bodlapati R, Mukherjee S, Venkata SGP, et al. Modulatory effects of biosynthesized gold nanoparticles conjugated with curcumin and paclitaxel on tumorigenesis and metastatic pathways—in vitro and in vivo studies. Int J Mol Sci. 2022;23(4):2150.
Article CAS PubMed Google Scholar
Lee WH, Loo CY, Traini D, Young PM. Development and evaluation of paclitaxel and curcumin dry powder for inhalation lung cancer treatment. Pharmaceutics. 2020;13(1):9.
Chelu M, Musuc AM, Popa M, Calderon Moreno J. Aloe vera-based hydrogels for wound healing: properties and therapeutic effects. Gels. 2023;9(7):539.
Article CAS PubMed Google Scholar
Solaberrieta I, Jiménez A, Garrigós MC. Valorization of aloe vera skin by-products to obtain bioactive compounds by microwave-assisted extraction: antioxidant activity and chemical composition. Antioxidants. 2022;11(6):1058.
Article CAS PubMed Google Scholar
Kumar S, Kalita S, Basumatary IB, Kumar S, Ray S, Mukherjee A. Recent advances in therapeutic and biological activities of aloe vera. Biocatal Agric Biotechnol. 2024;57:103084.
Koprulu TK, Balkan J. Investigation of antiproliferative, apoptotic and migration activity of combination of paclitaxel and aloe vera in non-small cell lung cancer and breast cancer. Haydarpasa Numune Med J. 2024. https://doi.org/10.14744/hnhj.2023.16046.
Weaver BA. How taxol/paclitaxel kills cancer cells. Mol Biol Cell. 2014;25(18):2677–81.
Ünlü A, Nayır E, Ay H, Kırca Ö, Özdoğan M. Aloe vera and cancer. Turk J Oncol. 2016;31(2):68–72. https://doi.org/10.5505/tjo.2016.1433.
Hussain A, Sharma C, Khan S, Shah K, Haque S. Aloe vera inhibits proliferation of human breast and cervical cancer cells and acts synergistically with cisplatin. Asian Pac J Cancer Prev. 2015;16(7):2939–46.
Yonehara A, Tanaka Y, Kulkeaw K, Era T, Nakanishi Y, Sugiyama D. Aloe vera extract suppresses proliferation of neuroblastoma cells in vitro. Anticancer Res. 2015;35(8):4479–85.
Wu YY, Zhang JH, Gao JH, Li YS. Aloe-emodin (AE) nanoparticles suppresses proliferation and induces apoptosis in human lung squamous carcinoma via ROS generation in vitro and in vivo. Biochem Biophys Res Commun. 2017;490(3):601–7.
Article CAS PubMed Google Scholar
Memarzia A, Saadat S, Asgharzadeh F, Behrouz S, Folkerts G, Boskabady MH. Therapeutic effects of medicinal plants and their constituents on lung cancer, in vitro, in vivo and clinical evidence. J Cell Mol Med. 2023;27(19):2841–63.
Article CAS PubMed Google Scholar
Shi R, Liu Z. RPL15 promotes hepatocellular carcinoma progression via regulation of RPs-MDM2-p53 signaling pathway. Cancer Cell Int. 2022;22(1):150.
Article CAS PubMed Google Scholar
Ebright RY, Lee S, Wittner BS, Niederhoffer KL, Nicholson BT, Bardia A, Truesdell S, Wiley D, Wesley B, Li S, et al. Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis. Science. 2020;367(6485):1468–73.
Article CAS PubMed Google Scholar
Wang H, Zhao LN, Li KZ, Ling R, Li XJ, Wang L. Overexpression of ribosomal protein L15 is associated with cell proliferation in gastric cancer. BMC Cancer. 2006;6:91.
Naora H, Takai I, Adachi M, Naora H. Altered cellular responses by varying expression of a ribosomal protein gene: sequential coordination of enhancement and suppression of ribosomal protein S3a gene expression induces apoptosis. J Cell Biol. 1998;141(3):741–53.
Article CAS PubMed Google Scholar
Zhou C, Weng J, Liu C, Zhou Q, Chen W, Hsu JL, Sun J, Atyah M, Xu Y, Shi Y, et al. High RPS3A expression correlates with low tumor immune cell infiltration and unfavorable prognosis in hepatocellular carcinoma patients. Am J Cancer Res. 2020;10(9):2768–84.
Owens KM, Kulawiec M, Desouki MM, Vanniarajan A, Singh KK. Impaired OXPHOS complex III in breast cancer. PLoS ONE. 2011;6(8):23846.
Gao SP, Sun HF, Jiang HL, Li LD, Hu X, Xu XE, Jin W. Loss of COX5B inhibits proliferation and promotes senescence via mitochondrial dysfunction in breast cancer. Oncotarget. 2015;6(41):43363.
Gao F, Liu Q, Li G, Dong F, Qiu M, Lv X, Zhang S, Guo Z. Identification of ubiquinol cytochrome c reductase hinge (UQCRH) as a potential diagnostic biomarker for lung adenocarcinoma. Open Biol. 2016;6(6):150256.
Gao SP, Sun HF, Fu WY, Li LD, Zhao Y, Chen MT, Jin W. High expression of COX5B is associated with poor prognosis in breast cancer. Future Oncol. 2017;13(19):1711–9.
留言 (0)